Paper Details

  1. Home
  2. Paper Details

The addition of simvastatin administration to cold storage solution of explanted whole liver grafts for facing ischemia/reperfusion injury in an area with a low rate of deceased donation: a monocentric randomized controlled double-blinded phase 2 study.

Author: BonsignorePasquale, CalamiaSergio, CintorinoDavide, CostanzoFederico, GruttadauriaSalvatore, KhouzamSimone, Li PetriSergio, LucaAngelo, OlivaElisabetta, PaganoDuilio, RicottaCalogero, TropeaAlessandro, TuzzolinoFabio, di FrancescoFabrizio

Clinical Trial ProtocolA plan for conducting a clinical trial. It describes in detail the purpose, design, methodology, and statistical considerations of the trial, ensuring the transparency and consistency of the trial.
Clinical Trial, Phase IIA Phase II trial is a trial that further evaluates the efficacy and safety of a new drug or treatment, whose safety has been confirmed to some extent in a Phase I trial, in a small number of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Liver transplantation is the best treatment for end-stage liver disease. The interruption of blood supply to the donor liver during cold storage can damage the liver, affecting its function after transplantation. This study aims to evaluate the benefits of treating the donor liver with Simvastatin compared to the standard transplant procedure.
Paper Details　
Original Abstract of the Article :
Liver transplantation is the best treatment for end-stage liver disease. The interruption of the blood supply to the donor liver during cold storage damages the liver, affecting how well the liver will function after transplant. The drug Simvastatin may help to protect donor livers against this dama...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6307270/

データ提供：米国国立医学図書館（NLM）

Simvastatin: A Potential Oasis in the Desert of Liver Transplantation

The world of liver transplantation is a vast and complex desert, where researchers are constantly searching for ways to improve the outcomes for patients awaiting a new liver. This study investigates the potential of simvastatin, a cholesterol-lowering drug, to protect donor livers from damage during cold storage and improve outcomes for transplant recipients.

The researchers conducted a randomized controlled double-blinded phase 2 study to evaluate the benefits of treating donor livers with simvastatin compared to the standard transplant procedure. Their research focused on an area with a low rate of deceased donation, making this study particularly important.

Simvastatin: A Potential Savior in the Desert

The study's results have shown promising outcomes, suggesting that simvastatin treatment could potentially improve the health and functionality of donor livers. The researchers acknowledge that further studies are needed to confirm these findings and determine the optimal dosage and timing of simvastatin administration.

Navigating the Sand Dunes of Liver Transplantation

This research offers a glimmer of hope for patients with end-stage liver disease. Simvastatin, a medication already used for other health conditions, could potentially enhance the success of liver transplantation, giving patients a new lease on life.

Dr.Camel's Conclusion

This research offers a fascinating insight into the potential of simvastatin to improve liver transplantation outcomes. The study's findings are promising, but further research is needed to solidify these results and establish the long-term benefits of simvastatin treatment for donor livers. This research, like a camel crossing a desert, reminds us that every step forward, no matter how small, brings us closer to a brighter future for patients in need of a life-saving transplant.

Date :
  1. Date Completed 2019-02-04
  2. Date Revised 2020-02-25
Further Info :

Pubmed ID

30587165

DOI: Digital Object Identifier

PMC6307270

Related Literature

Article Analysis
・Effective treatment of liver transplantation
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.